Prudential Financial
ORGO icon

Prudential Financial’s Organogenesis Holdings ORGO Stock Holding History

Prudential Financial’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.5K Sell
10,500
-135,400
-93% -$331K ﹤0.01% 2467
2026
Q1 		$346K Sell
145,900
-24,290
-14% -$84.1K ﹤0.01% 1982
2025
Q4 		$882K Buy
170,190
+93,590
+122% +$453K ﹤0.01% 1637
2025
Q3 		$323K Sell
76,600
-114,600
-60% -$533K ﹤0.01% 2083
2025
Q2 		$700K Sell
191,200
-38,860
-17% -$145K ﹤0.01% 1812
2025
Q1 		$994K Sell
230,060
-7,660
-3% -$30.9K ﹤0.01% 1571
2024
Q4 		$761K Buy
237,720
+114,500
+93% +$384K ﹤0.01% 1683
2024
Q3 		$352K Buy
123,220
+2,800
+2% +$7.85K ﹤0.01% 2356
2024
Q2 		$337K Buy
120,420
+1,800
+2% +$4.83K ﹤0.01% 2314
2024
Q1 		$337K Buy
118,620
+76,800
+184% +$261K ﹤0.01% 2299
2023
Q4 		$171K Sell
41,820
-32,000
-43% -$89.6K ﹤0.01% 2464
2023
Q3 		$235K Sell
73,820
-31,900
-30% -$101K ﹤0.01% 2339
2023
Q2 		$351K Sell
105,720
-286,850
-73% -$848K ﹤0.01% 2248
2023
Q1 		$836K Sell
392,570
-104,635
-21% -$259K ﹤0.01% 1828
2022
Q4 		$1.34M Buy
497,205
+23,300
+5% +$68K ﹤0.01% 1544
2022
Q3 		$1.54M Buy
473,905
+27,700
+6% +$125K ﹤0.01% 1505
2022
Q2 		$2.18M Sell
446,205
-79,909
-15% -$492K ﹤0.01% 1344
2022
Q1 		$4.01M Sell
526,114
-59,366
-10% -$459K 0.01% 1090
2021
Q4 		$5.41M Sell
585,480
-4,834
-0.8% -$51.3K 0.01% 985
2021
Q3 		$8.41M Sell
590,314
-3,527
-0.6% -$54.8K 0.01% 784
2021
Q2 		$9.87M Buy
593,841
+91,421
+18% +$1.7M 0.01% 766
2021
Q1 		$9.15M Buy
+502,420
New +$6.81M 0.01% 801

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Prudential Financial's ORGO Position: Q2 2026 in Review

Prudential Financial reduced its Organogenesis Holdings (ORGO) stake by 93% in Q2 2026, selling an estimated $331K and leaving 10,500 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2467.

Prudential Financial first reported a position in ORGO in Q1 2021 and has held it in 22 quarters since. The position peaked at $9.87M in Q2 2021. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Prudential Financial held 10,500 shares of Organogenesis Holdings worth $25.5K as of Q2 2026.
  • Prudential Financial sold 135,400 Organogenesis Holdings shares in Q2 2026, an estimated $331K.
  • Organogenesis Holdings made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2467 holding.
  • Prudential Financial first reported a position in Organogenesis Holdings in Q1 2021 and has held it in 22 quarters since.
  • Prudential Financial's Organogenesis Holdings position peaked at $9.87M in Q2 2021.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.